Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Prison suicide rate five times higher – new study aims to fix prevention tools

NCT ID NCT07259408

Knowledge-focused Sponsor: University Ghent Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

People in detention are at much higher risk of suicide than the general population. This study works with 40 participants—20 prison staff and 20 detained individuals—to adapt three suicide prevention tools for use in prisons. Through interviews, researchers will gather feedback to make these tools more practical and effective in the unique prison environment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to better, more practical suicide prevention tools tailored for prisons, potentially reducing suicide rates among detained individuals.
What could go wrong
This is a small, early-stage study with only 40 participants, so findings may not apply broadly. The tools may still face implementation challenges in real-world detention settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants will be drawn from Belgian detention facilities and the prison-based care network. Specifically: * Professionals working in detention: Psychologists, psychiatrists, social workers, nurses, and other healthcare staff working within Belgian detention centers who have had experience in suicide prevention. * People in detention: Adults held in selected Belgian prisons who are clinically stable and able to participate in a one-hour interview. Referrals will be made by prison psychologists, social workers, or healthcare staff.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

For professionals working in detention: Inclusion criteria: * Aged 18 years or older * Currently working in a professional care role within a prison setting (e.g., psychologist, psychiatirst, social worker, nurse, etc.) * Experience in supporting or treating incarcerated individuals with suicidal thoughts or behaviours Exclusion Criteria: * Under the age of 18 * Not employed in a professional caregiving role within detention (e.g., correctional officers or security staff) For people in detention: Inclusion criteria: * Aged 18 years or older * Experienced suicidal thoughts within the past three years Exclusion criteria: * Under the age of 18 * Significant cognitive limitations that would make the participation in an interview infeasible * Insufficient command of the Dutch language to understand and respond to interview questions

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Suicidal ideation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Suicidal Ideation Suicide Suicide Prevention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Suicidal ideation Suicide Suicide prevention

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Flemish Centre of Expertise in Suicide Prevention, Ghent University

    RECRUITING

    Ghent, East-Flanders, 9000, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.